Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07133412 · ClinicalTrials.gov registry record · NA

An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph

A NA study, sponsored by Joseph D. Tobias.

Not yet
Registry status
NA
Development phase
100
Enrollment target

NCT07133412: Clinical Trial NA study, sponsored by Joseph D. Tobias.

NCT07133412 is a NA study that has not yet begun recruiting, run by Joseph D. Tobias. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07133412, a NA study, has not yet begun recruiting, sponsored by Joseph D. Tobias.

NOT YET RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).

Primary Outcome

Average amplitude of the evoked response of the muscles.

Interventions

  • DEVICE TetraGraph

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-07
Est. Completion 2027-12
Phase NA
Joseph D. Tobias

21 total trials

What is known before NCT07133412 opens enrollment

NCT07133412 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which TetraGraph is the first listed.

NCT07133412 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07133412 about?

NCT07133412 is a clinical study titled "An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph". The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).

What is the current status of trial NCT07133412?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2027-12.

What interventions are being tested in trial NCT07133412?

The interventions under investigation include: TetraGraph (DEVICE).

Who is sponsoring clinical trial NCT07133412?

This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07133412's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07133412, the US trial registry maintained by the National Library of Medicine. NCT07133412 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.